Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Head-to-head comparison of Baxter and GSK H1N1 pandemic vaccines
2009-015743-16Phase 3Completed
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in H1N1 influenza (H1N1) (2 arms), sponsored by University Hospitals of Leicester NHS Trust. Primary endpoint: Measures of immunogenicity. Started Oct 2009; status: completed.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
H1N1 influenza (H1N1)
Beyond the preview
Go deeper on 2009-015743-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015743-16.